IMAGE ANALYSIS GROUP is attending the World Medical Innovation Forum on the 22nd to 23rd of September in Boston.
Public source
Publisher name
Public post
We're excited to be heading to the ๐๐จ๐ซ๐ฅ๐ ๐๐๐๐ข๐๐๐ฅ ๐๐ง๐ง๐จ๐ฏ๐๐ญ๐ข๐จ๐ง ๐ ๐จ๐ซ๐ฎ๐ฆ this ๐๐๐ฉ๐ญ๐๐ฆ๐๐๐ซ ๐๐โ๐๐ ๐ข๐ง ๐๐จ๐ฌ๐ญ๐จ๐ง! ๐ Our VP of Business Dโฆ
Company
IMAGE ANALYSIS GROUP
Imaging | Clinical Trials | Powered by DYNAMIKAโข | Fueled by Expertise
- Industry
- Biotechnology Research
- Location
- London, GB
- Company size
- 51โ200 employees
About IMAGE ANALYSIS GROUP
Image Analysis Group (IAG) is a global imaging CRO and imaging core lab for biotech and pharma sponsors. IAG delivers end-to-end medical imaging services for clinical trials that use imaging to assess drug safety and efficacy, supporting Phase I to Phase IV studies in oncology, rheumatology, orthopedics, obesity, cardiology, hepatology, neurology, and rare disease. What is an imaging CRO? IAG designs and executes the imaging component of a clinical trial - from imaging endpoint strategy through to regulatory submission - using a centralized imaging core lab model. Imaging modalities supported: X-ray, DXA, CT, MRI, DCE-MRI, functional MRI, PET, PET/CT, PET/MR, SPECT, ultrasound, and cardiac safety imaging. Services: โข Imaging endpoint strategy and protocol design - imaging biomarkers and scoring systems including RECIST, iRECIST, mRECIST, RANO, Sharp, van der Heijde, RAMRIS, OARSI, KellgrenโLawrence, and PDFF; feasibility, sample size, and regulatory alignment with FDA, EMA, MHRA, and PMDA โข Imaging Charter, Imaging Manual, Imaging Review Charter, and SOPs aligned to ICH-GCP and 21 CFR Part 11 โข Site qualification, technologist training, positioning kits, and 24/5 multilingual site support โข Secure DICOM image collection, transfer, de-identification, technical and protocol QC, and audit trail โข Centralized independent radiological review by board-certified radiologists, with chronological, paired, and randomized reading paradigms and third-reader adjudication โข Quantitative imaging and AI-based analysis via DYNAMIKAโข, IAG's proprietary platform for automated quantification of synovitis, bone marrow edema, erosions, tumor volumetrics, perfusion, diffusion, and liver fat fraction โข Regulatory support for IND, IMPD, NDA, BLA, and MAA submissions and FDA Type B and C meetings ISO 27001, ISO 9001, GDPR, HIPAA, and 21 CFR Part 11 compliant. Global operations across the UK, EU, US, and APAC. Contact IAG to scope your next imaging trial: contact@ia-grp.com
See moreLatest activity
Latest activity from IMAGE ANALYSIS GROUP
6 signals
Presence & Recognition
IMAGE ANALYSIS GROUP is attending the H.C. Wainwright & Co., LLC 28th Annual Global Investment Conference in New York, USA on September 14โ15, 2026, featuring Dr. Olga Kubassova and Mike Fisher PhD FRSC.
Presence & Recognition
IMAGE ANALYSIS GROUP will be attending the World Medical Innovation Forum on September 22โ23.
Presence & Recognition
IMAGE ANALYSIS GROUP celebrated 19 years of operations, focused on bringing meaningful technology into drug development.
Discover more
Similar signals
Similar public activity from other companies.
Presence & Recognition
PhaseV
PhaseV is attending the World Medical Innovation Forum in Boston from September 22 to 23 to discuss clinical development and AI applications.
Presence & Recognition
Perceptive Inc.
Perceptive Inc. is presenting new research on an imaging-enabled orthotopic PDAC model combining patient-derived 3D spheroids with longitudinal MRI and ultrasound at the WMIC 2026 opening poster session.
Presence & Recognition
Inductive Bio
Inductive Bio is hosting the Discovery on Target 2026 conference in Boston on September 28 to October 1, featuring a speaking slot and a booth.
Presence & Recognition
PixeSci
PixeSci will be attending the Hynes Convention Center from September 29 to 30, 2026, to meet biotech, pharma, and health tech professionals pushing AI and precision medicine forward.
Presence & Recognition
BIOEMTECH